Infective endocarditis remains a diagnostic challenge. Although echocardiography is still the mainstay imaging test, it misses up to 30% of cases. Newer imaging tests-4-dimensional computed tomography (4D CT), fl uorodeoxy glucose positron emission tomography (FDG-PET), and leukocyte scintigraphy-are increasingly used as alternative or adjunct tests for select patients. They improve the sensitivity of clinical diagnosis of infective endocarditis when appropriately used, especially in the setting of a prosthetic valve.
P
rompt diagnosis of infective endocarditis is critical. Potential consequences of missed or delayed diagnosis, including heart failure, stroke, intracardiac abscess, conduction delays, prosthesis dysfunction, and cerebral emboli, are often catastrophic. Echocardiography is the test used most frequently to evaluate for infective endocarditis, but it misses the diagnosis in almost one-third of cases, and even more often if the patient has a prosthetic valve.
But now, several sophisticated imaging tests are available that complement echocardiography in diagnosing and assessing infective endocarditis; these include 4-dimensional computed tomography (4D CT), fl uorodeoxyglucose positron emission tomography (FDG-PET), and leukocyte scintigraphy. These tests have greatly improved our ability not only to diagnose infective endocarditis, but also to determine the extent and spread of infection, and they aid in perioperative assessment. Abnormal fi ndings on these tests have been incorporated into the European Society of Cardiology's 2015 modifi ed diagnostic criteria for infective endocarditis. 1 This article details the indications, advantages, and limitations of the various imaging tests for diagnosing and evaluating infective endocarditis ( Table 1) .
■ INFECTIVE ENDOCARDITIS IS DIFFICULT TO DIAGNOSE AND TREAT
Infective endocarditis is diffi cult to diagnose and treat. Clinical and imaging clues can be subtle, and the diagnosis requires a high level of suspicion and visualization of cardiac structures. Further, the incidence of infective endocarditis is on the rise in the United States, particularly in women and young adults, likely due to intravenous drug use. 2, 3 
■ ECHOCARDIOGRAPHY HAS AN IMPORTANT ROLE, BUT IS LIMITED
Echocardiography remains the most commonly performed study for diagnosing infective endocarditis, as it is fast, widely accessible, and less expensive than other imaging tests. Transthoracic echocardiography (TTE) is often the fi rst choice for testing. However, its sensitivity is only about 70% for detecting vegetations on native valves and 50% for detecting vegetations on prosthetic valves. 1 It is inherently constrained by the limited number of views by which a comprehensive external evaluation of the heart can be achieved. Using a 2-dimensional instrument to view a 3-dimensional object is diffi cult, and depending on several factors, it can be hard to see vegetations and abscesses that are associated with infective endocarditis. Further, TTE is impeded by obesity and by hyperinfl ated lungs from obstructive pulmonary disease or mechanical ventilation. It has poor sensitivity for detecting small vegetations and for detecting vegetations and paravalvular complications in patients who have a prosthetic valve or a cardiac implanted electronic device.
Transesophageal echocardiography (TEE) is the recommended fi rst-line imaging test for patients with prosthetic valves and no contraindications to the test. Otherwise, it should be done after TTE if the results of TTE are negative but clinical suspicion for infective endocarditis remains high (eg, because the patient uses intravenous drugs). But although TEE has a higher sensitivity than TTE (up to 96% for vegetations on native valves and 92% for those on prosthetic valves, if performed by an experienced sonographer), it can still miss infective endocarditis. Also, TEE does not provide a signifi cant advantage over TTE in patients who have a cardiac implanted electronic device. 1, 4, 5 Regardless of whether TTE or TEE is used, they are estimated to miss up to 30% of cases of infective endocarditis and its sequelae. 4 False-negative fi ndings are likelier in patients who have preexisting severe valvular lesions, prosthetic valves, cardiac implanted electronic devices, small vegetations, or abscesses, or if a vegetation has already broken free and embolized. Furthermore, distinguishing between vegetations and thrombi, cardiac tumors, and myxomatous changes using echocardiography is diffi cult.
■ CARDIAC CT
For patients who have inconclusive results on echocardiography, contraindications to TEE, or poor sonic windows, cardiac CT can be an excellent alternative. It is especially useful in the setting of a prosthetic valve.
Synchronized ("gated") with the patient's heart rate and rhythm, CT machines can acquire images during diastole, reducing motion artifact, and can create 3D images of the heart. In addition, newer machines can acquire several images at different points in the heart cycle to add a fourth dimension-time. The resulting 4D images play like short video loops of the beating heart and allow noninvasive assessment of cardiac anatomy with remarkable detail and resolution.
4D CT is increasingly being used in infective endocarditis, and growing evidence indicates that its accuracy is similar to that of TEE in the preoperative evaluation of patients with aortic prosthetic valve endocarditis. 6 In a study of 28 patients, complementary use of CT angiography led to a change in treatment strategy in 7 (25%) compared with routine clinical workup. 7 Several studies have found no difference between 4D CT and preoperative TEE in detecting pseudoaneurysm, abscess, or valve dehiscence. TEE and 4D CT also have similar sensitivities for detecting infective endocarditis in native and prosthetic valves. 8, 9 Coupled with CT angiography, 4D CT is also an excellent noninvasive way to perioperatively evaluate the coronary arteries without the risks associated with catheterization in those requiring nonemergency surgery ( Figure  1A , B, and C).
4D CT performs well for detecting abscess and pseudoaneurysm but has slightly lower sensitivity for vegetations than TEE (91% vs 99%). 9 Gated CT, PET, or both may be useful in cases of suspected prosthetic aortic valve en- 
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Echocardiography misses the diagnosis in almost 1/3 of cases docarditis when TEE is negative. Pseudoaneurysms are not well visualized with TEE, and the atrial mitral curtain area is often thickened on TEE in cases of aortic prosthetic valve infective endocarditis that do not defi nitely involve abscesses. Gated CT and PET show this area better. 8 This information is important in cases in which a surgeon may be unconvinced that the patient has prosthetic valve endocarditis.
Limitations of 4D cardiac CT
Patients with irregular heart rhythms or uncontrolled tachycardia pose technical problems for image acquisition. Cardiac CT is typically gated (ie, images are obtained within a defi ned time period) to acquire images during diastole. Ideally, images are acquired when the heart is in mid to late diastole, a time of minimal cardiac motion, so that motion artifact is minimized. To estimate the timing of image acquisition, the cardiac cycle must be predictable, and its duration should be as long as possible. Tachycardia or irregular rhythms such as frequent ectopic beats or atrial fi brillation make acquisition timing diffi cult, and thus make it nearly impossible to accurately obtain images when the heart is at minimum motion, limiting assessment of cardiac structures or the coronary tree. 4, 10 Extensive coronary calcifi cation can hinder assessment of the coronary tree by CT coronary angiography .
Contrast exposure may limit the use of CT in some patients (eg, those with contrast allergies or renal dysfunction). However, modern scanners allow for much smaller contrast boluses without decreasing sensitivity.
4D CT involves radiation exposure, especially when done with angiography, although modern scanners have greatly reduced exposure. The average radiation dose in CT coronary angiography is 2.9 to 5.9 mSv 11 compared with 7 mSv in diagnostic cardiac catheterization (without angioplasty or stenting) or 16 mSv in routine CT of the abdomen and pelvis with contrast. 12, 13 In view of the morbidity and mortality risks associated with infective endocarditis, especially if the diagnosis is delayed, this small radiation exposure may be justifi able. 
Bottom line for cardiac CT
■ FDG-PET AND LEUKOCYTE SCINTIGRAPHY
FDG-PET and leukocyte scintigraphy are other options for diagnosing infective endocarditis and determining the presence and extent of intra-and extracardiac infection. They are more sensitive than echocardiography for detecting infection of cardiac implanted electronic devices such as ventricular assist devices, pacemakers, implanted cardiac defi brillators, and cardiac resynchronization therapy devices. [14] [15] [16] The utility of FDG-PET is founded on the uptake of 18 F-fl uorodeoxyglucose by cells, with higher uptake taking place in cells with higher metabolic activity (such as in areas of infl ammation). Similarly, leukocyte scintigraphy relies on the use of radiolabeled leukocytes (ie, leukocytes previously extracted from the patient, labelled, and re-introduced into the patient) to allow for localization of infl amed tissue.
The most signifi cant contribution of FDG-PET may be the ability to detect infective endocarditis early, when echocardiography is initially negative. When abnormal FDG uptake was included in the modifi ed Duke criteria, it increased the sensitivity to 97% for detecting infective endocarditis on admission, Infective endocarditis is on the rise, likely due to intravenous drug use leading some to propose its incorporation as a major criterion. 17 In patients with prosthetic valves and suspected infective endocarditis, FDG-PET was found in one study to have a sensitivity of up to 91% and a specifi city of up to 95%. 18 Both FDG-PET and leukocyte scintigraphy have a high sensitivity, specifi city, and negative predictive value for cardiac implanted electronic device infection, and should be strongly considered in patients in whom it is suspected but who have negative or inconclusive fi ndings on echocardiography. 14, 15 In addition, a common conundrum faced by clinicians with use of echocardiography is the diffi culty of differentiating thrombus from infected vegetation on valves or device lead wires. Some evidence indicates that FDG-PET may help to discriminate between vegetation and thrombus, although more rigorous studies are needed before its use for that purpose can be recommended.
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Limitations of nuclear studies Both FDG-PET and leukocyte scintigraphy perform poorly for detecting native-valve infective endocarditis. In a study in which 90% of the patients had native-valve infective endocarditis according to the Duke criteria, FDG-PET had a specifi city of 93% but a sensitivity of only 39%. 20 Both studies can be cumbersome, laborious, and time-consuming for patients. FDG-PET requires a fasting or glucose-restricted diet before testing, and the test itself can be complicated by development of hyperglycemia, although this is rare.
While FDG-PET is most effective in detecting infections of prosthetic valves and cardiac implanted electronic devices, the results can be falsely positive in patients with a history of recent cardiac surgery (due to ongoing tissue healing), as well as maladies other than infective endocarditis that lead to infl ammation, such as vasculitis or malignancy. Similarly, for unclear reasons, leukocyte scintigraphy can yield false-negative results in patients with enterococcal or candidal infective endocarditis. 21 FDG-PET and leukocyte scintigraphy are more expensive than TEE and cardiac CT 22 and are not widely available.
Both tests entail radiation exposure, with the average dose ranging from 7 to 14 mSv. However, this is less than the average amount acquired during percutaneous coronary intervention (16 mSv), and overlaps with the amount in chest CT with contrast when assessing for pulmonary embolism (7 to 9 mSv). Lower doses are possible with optimized protocols. 12, 13, 15, 23 Bottom line for nuclear studies FDG-PET and leukocyte scintigraphy are especially useful for patients with a prosthetic valve or cardiac implanted electronic device. However, limitations must be kept in mind.
A suggested algorithm for testing with nuclear imaging is shown in Figure 2 .
1,4 ■ CEREBRAL MAGNETIC RESONANCE IMAGING
Cerebral magnetic resonance imaging (MRI) is more sensitive than cerebral CT for detecting emboli in the brain. According to American Heart Association guidelines, cerebral MRI should be done in patients with known or suspected infective endocarditis and neurologic impairment, defi ned as headaches, meningeal symptoms, or neurologic defi cits. It is also often used in neurologically asymptomatic patients with infective endocarditis who have indications for valve surgery to assess for mycotic aneurysms, which are associated with increased intracranial bleeding during surgery. MRI use in other asymptomatic patients remains controversial. 24 In cases with high clinical suspicion for infective endocarditis and no fi ndings on echocardiography, cerebral MRI can increase the sensitivity of the Duke criteria by adding a minor criterion. Some have argued that, in patients with defi nite infective endocarditis, detecting silent cerebral complications can lead to management changes. However, more studies are needed to determine if there is indeed a group of neurologically asymptomatic infective endocarditis patients for whom cerebral MRI leads to improved outcomes.
Limitations of cerebral MRI
Cerebral MRI cannot be used in patients with non-MRI-compatible implanted hardware.
Gadolinium, the contrast agent typically . Its use should be avoided in patients with renal failure on replacement therapy, with advanced chronic kidney disease (glomerular fi ltration rate < 30 mL/min/1.73 m 2 ), or with acute kidney injury, even if they do not need renal replacement therapy. 25 Concerns have also been raised about gadolinium retention in the brain, even in patients with normal renal function. [26] [27] [28] Thus far, no conclusive clinical adverse effects of retention have been found, although more study is warranted. Nevertheless, the US Food and Drug Administration now requires a black-box warning about this possibility and advises clinicians to counsel patients appropriately. TEE is the recommended fi rst-line study for patients with a prosthetic valve those without defi nite infective endocarditis, is discouraged.
Bottom line on cerebral MRI
■ CARDIAC MRI
Cardiac MRI, typically obtained with gadolinium contrast, allows for better 3D assessment of cardiac structures and morphology than echocardiography or CT, and can detect infi ltrative cardiac disease, myopericarditis, and much more. It is increasingly used in the fi eld of structural cardiology, but its role for evaluating infective endocarditis remains unclear. Cardiac MRI does not appear to be better than echocardiography for diagnosing infective endocarditis. However, it may prove helpful in the evaluation of patients known to have infective endocarditis but who cannot be properly evaluated for disease extent because of poor image quality on echocardiography and contraindications to CT. 1, 29 Its role is limited in patients with cardiac implanted electronic devices, as most devices are incompatible with MRI use, although newer devices obviate this concern. But even for devices that are MRIcompatible, results are diminished due to an eclipsing effect, wherein the device parts can make it hard to see structures clearly because the "brightness" basically eclipses the surrounding area. 4 Concerns regarding use of gadolinium as described above need also be considered.
The role of cardiac MRI in diagnosing and managing infective endocarditis may evolve, but at present, the 2017 American College of Cardiology and American Heart Association appropriate-use criteria discourage its use for these purposes.
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Bottom line for cardiac MRI Cardiac MRI to evaluate a patient for suspected infective endocarditis is not recommended due to lack of superiority compared with echocardiography or CT, and the risk of nephrogenic systemic fi brosis from gadolinium in patients with renal compromise.
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